Retour sur lavenir.net
   RECTICEL 11.700 € (-0,85 %)     WDP 22.140 € (+0,54 %)     AB INBEV 71.500 € (+1,10 %)     AZELIS GROUP 10.820 € (-1,46 %)     ONTEX GROUP 2.355 € (+0,64 %)     UMICORE 19.020 € (-1,30 %)     ARGENX SE 744.400 € (-0,77 %)     VGP 80.400 € (-0,25 %)     XIOR 27.900 € (+0,54 %)     UCB 236.100 € (-0,67 %)     D'IETEREN GROUP 174.400 € (-0,51 %)     KBC ANCORA 84.400 € (-1,40 %)     KBC 120.050 € (-1,60 %)     MELEXIS 69.500 € (-2,66 %)     ELIA GROUP 136.200 € (+0,81 %)     IBA 16.920 € (-0,47 %)     PROXIMUS 6.160 € (+0,49 %)     FAGRON 23.950 € (-0,42 %)     TUBIZE-FIN 205.200 € (-1,16 %)     CARE PROPERTY INV. 12.800 € (+0,47 %)     BARCO 8.000 € (0,00 %)     SIPEF 91.300 € (+0,22 %)     TESSENDERLO 21.350 € (+1,18 %)     DECEUNINCK 2.200 € (-0,90 %)     AGFA-GEVAERT 0.405 € (+0,87 %)     HOME INVEST BE. 19.280 € (+0,21 %)     AGEAS 70.950 € (-0,14 %)     BPOST 1.588 € (0,00 %)     EVS 26.500 € (-0,56 %)     SOLVAY 25.980 € (-0,76 %)     GBL 77.750 € (-0,06 %)     RETAIL ESTATES 68.700 € (+0,59 %)     AEDIFICA 70.200 € (+0,50 %)     ATENOR 1.605 € (-2,73 %)     ACKERMANS V.HAAREN 271.000 € (0,00 %)     SOFINA 225.400 € (-0,44 %)     ASCENCIO 51.700 € (-0,39 %)     ORANGE BELGIUM 21.600 € (0,00 %)     KINEPOLIS GROUP 38.050 € (-0,39 %)     CENERGY 20.300 € (-1,26 %)     COLRUYT 38.360 € (+0,47 %)     ONWARD MEDICAL 2.480 € (-0,40 %)     CMB.TECH 13.420 € (-2,75 %)     SHURGARD 26.950 € (+0,94 %)     TITAN S.A. 49.000 € (-1,69 %)     MONTEA 67.900 € (+0,74 %)     TINC 11.180 € (-0,71 %)     DEME GROUP 169.800 € (-1,16 %)     WERELDHAVE BELGIUM 52.400 € (-1,87 %)     LOTUS BAKERIES 11 020.000 € (-0,18 %)     JENSEN-GROUP 85.000 € (-1,16 %)     CIE BOIS SAUVAGE 300.000 € (0,00 %)     BANIMMO A 2.920 € (-0,68 %)     SYENSQO 68.200 € (-0,37 %)     BIOTALYS 2.950 € (-0,67 %)     OXURION 0.003 € (0,00 %)     BANQUP GROUP 2.200 € (+0,92 %)     BELYSSE GROUP 0.450 € (-2,17 %)     GIMV 44.450 € (-0,67 %)     CFE 12.400 € (+2,90 %)  
   NETMEDIA GROUP 0.460 € (+2,22 %)     CVC CAPITAL 14.770 € (+0,41 %)     FERMENTALG 0.498 € (-4,33 %)     ATON 0.011 € (+3,64 %)     FDJ UNITED 23.240 € (-0,34 %)     FERROVIAL 55.700 € (-0,32 %)     EXOSENS 54.950 € (-1,26 %)     LIGHTON 4.710 € (-4,07 %)     ABL Diagnostics 2.380 € (+2,59 %)     PULLUP ENTERTAIN 8.240 € (-3,51 %)     NICOX 0.376 € (-0,53 %)     STIF 51.900 € (+0,78 %)     VIRIDIEN 75.850 € (-1,04 %)     AYVENS 11.640 € (-0,77 %)     NOVACYT 0.440 € (-4,35 %)     VALLOUREC 20.420 € (-0,54 %)     XILAM ANIMATION 5.360 € (+14,04 %)     ASML HOLDING 1 537.600 € (-3,80 %)     HERMES INTL 1 694.000 € (-0,70 %)     SOITEC 87.080 € (-3,44 %)     VIVENDI SE 1.900 € (-0,47 %)     TOTALENERGIES 69.590 € (0,00 %)     BNP PARIBAS ACT.A 101.400 € (-1,50 %)     SHELL PLC 37.595 € (+0,93 %)     KPN KON 4.336 € (+1,03 %)     LUMIBIRD 28.150 € (+9,53 %)     THE NAVIGATOR COMP 3.144 € (0,00 %)     ENGIE 26.840 € (+0,71 %)     RENAULT 26.560 € (-1,23 %)     BE SEMICONDUCTOR 227.900 € (-3,51 %)     KALRAY 8.240 € (+5,64 %)     ASM INTERNATIONAL 864.600 € (-4,57 %)     EXAIL TECHNOLOGIES 123.800 € (+0,24 %)     UNILEVER 55.140 € (+1,06 %)     ABN AMRO BANK N.V. 37.550 € (-1,34 %)     WOLTERS KLUWER 62.880 € (+0,29 %)     2CRSI 23.600 € (-3,04 %)     VALERIO TX 0.574 € (-3,85 %)     GTT 186.800 € (-0,43 %)     NANOBIOTIX 31.560 € (-5,73 %)     SEMCO TECHNOLOGIES 41.300 € (-4,18 %)     PROSUS 39.295 € (-2,80 %)     DANONE 73.560 € (+1,10 %)     DBV TECHNOLOGIES 2.704 € (-3,57 %)     MERCIALYS 11.620 € (+0,52 %)     PERNOD RICARD 66.480 € (+0,64 %)     SANOFI 77.320 € (+0,49 %)     STMICROELECTRONICS 53.340 € (-4,73 %)     NN GROUP 77.680 € (-0,41 %)     CAPITAL B 0.498 € (-4,80 %)     BIOMERIEUX 72.850 € (+0,21 %)     AHOLD DEL 36.270 € (+0,97 %)     CREDIT AGRICOLE 17.755 € (-0,92 %)     AIRBUS 192.380 € (-1,66 %)     SAFRAN 324.200 € (-1,49 %)     L'OREAL 383.000 € (+0,43 %)     ING GROEP N.V. 28.400 € (-1,53 %)     BOUYGUES 48.020 € (+0,67 %)     ADYEN 849.900 € (-0,48 %)     AMUNDI 89.350 € (-0,56 %)  
News Réglementées
04/05/2023 13:46

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

04-May-2023 / 12:46 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

03 May 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,584,808

9.44%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,584,808

9.44%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

2,031

110.80 USD

US$0.0001 ordinary shares

Sale

1,388

110.80 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 none

<

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière